AstraZeneca opens R&D center in Cambridge, Massachusetts

Go back to AstraZeneca opens R&D center in Cambridge, Massachusetts

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

October 5, 2026 12:01 PM EDT

$1 billion investment will grow AstraZenecas workforce in Massachusetts by over 50% and deliver next-generation medicines

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca today announced the opening of its newest global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Companys existing presence in Cambridge and Boston and places its scientists at the heart of one of the worlds most innovative life sciences ecosystems.

This press release features multimedia. View the full release here:... More